Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Polychemotherapy

Known as: Polychemotherapies 
 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Combination Drug Therapy

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Cisplatin-Induced Apoptosis Inhibits Autophagy, Which Acts as a Pro-Survival Mechanism in Human Melanoma Cells
The interplay between a non-lethal autophagic response and apoptotic cell death is still a matter of debate in cancer cell… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Highly Cited
2011
Highly Cited
2011
Outcome of children and adolescents with relapsed acute lymphoblastic leukaemia and non-response to salvage protocol therapy: a retrospective analysis of the ALL-REZ BFM Study Group.
AIM OF THE STUDY Non-response (NR) to treatment of childhood relapsed acute lymphoblastic leukaemia (ALL) is an end-point of… Expand
2009
2009
Treatment of cutaneous B-cell lymphoma, leg type, with age-adapted combinations of chemotherapies and rituximab.
I n contrast with most primary cutaneous B-cell lymphomas, primary cutaneous large B-cell lymphomas, leg type (PCLBCLs-LT) are… Expand
Highly Cited
2004
Highly Cited
2004
A computational model of human granulopoiesis to simulate the hematotoxic effects of multicycle polychemotherapy.
Moderate intensification of conventional multicycle chemotherapy has recently been shown to improve treatment results in… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Review
2004
Review
2004
Docetaxel–Anthracycline Combinations in Metastatic Breast Cancer
The taxanes and anthracyclines have emerged as the most active agents for treating women with advanced breast cancer. As such… Expand
  • table 1
  • table 2
Review
2001
Review
2001
Taxane/anthracycline combinations: setting a new standard in breast cancer?
Among the novel chemotherapeutic drugs introduced in the 1990s, the taxanes have emerged as the most powerful compounds in breast… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Highly Cited
1996
Highly Cited
1996
Complications of venous access ports in 132 patients with disseminated testicular cancer treated with polychemotherapy.
PURPOSE Venous access ports (VAPs) can be used to administer polychemotherapy to patients with malignancies. The purpose of this… Expand
  • table 2
  • table 4
1993
1993
Subcutaneous Therapy with Low-Dose Interleukin-2 plus the Neurohormone Melatonin in Metastatic Gastric Cancer Patients with Low Performance Status
Aims and background Patients with disseminated gastric cancer are generally in very bad clinical conditions, which make them not… Expand
  • table 1
  • table 2
1986
1986
[Polychemotherapy of ovarian cancer via combined intravenous and intraperitoneal routes. Technic and preliminary results].
20 patients with F.I.G.O. stages III ovarian cancer were entered into a randomised trial between January 1980 and March 1984… Expand
1982
1982
[Simultaneous or sequential hormono/chemotherapy and a comparison of various polychemotherapies in the treatment of metastatic breast cancer].
Since in the treatment of advanced breast cancer chemotherapy and the various hormonal manipulations seem recently to have… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE